Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87,001,862
-
Total 13F shares
-
67,619,494
-
Share change
-
-948,953
-
Total reported value
-
$1,409,907,095
-
Put/Call ratio
-
35%
-
Price per share
-
$20.85
-
Number of holders
-
163
-
Value change
-
-$33,759,405
-
Number of buys
-
84
-
Number of sells
-
64
Institutional Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q2 2021
As of 30 Jun 2021 Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) had 163 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 67,619,494 shares of stock of the company.
Largest 10 holders included FMR LLC, BlackRock Inc., Avoro Capital Advisors LLC, EcoR1 Capital, LLC, VANGUARD GROUP INC, STATE STREET CORP, Holocene Advisors, LP, AMERIPRISE FINANCIAL INC, WELLINGTON MANAGEMENT GROUP LLP, and Foresite Capital Management IV, LLC.
This table shows 163 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.